Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

TELLYES SCIENTIFIC

Request full access

Innovative medical education solutions featuring advanced VR technology and high-end simulation products

Nankai District, ChinaFounded 2011

About TELLYES SCIENTIFIC

Tellyes Scientific Inc. is a high-tech enterprise specializing in the research, development, production, and sales of modern medical education products. The company, which went public on the NEEQ in July 2015 under the stock symbol 833047, focuses on technological innovation and the development of products with independent intellectual property rights. Tellyes is a leader in virtual reality technology and services for medical education and is recognized as the enterprise Technology Center of Tianjin and the Engineering Center of Traditional Chinese Medicine and Medical Virtual Technology.

Tellyes serves educational institutions, medical schools, and healthcare professionals by providing highly realistic medical simulation products. These products include CPR defibrillation manikins with highly simulated anatomical structures and LungsReady breathing simulators capable of simulating respiratory diseases across different ages and genders. The company operates in the medical education market, offering solutions that enhance the training and preparedness of healthcare providers.

The business model of Tellyes revolves around the sale of its advanced medical simulation products and services. Revenue is generated through direct sales to educational institutions and healthcare organizations, as well as through partnerships and collaborations with other entities in the medical education sector.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2015

TELLYES SCIENTIFIC in the Nankai District ecosystem

Live from Dealroom

The TELLYES SCIENTIFIC office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Shanghai Capital

Series A3 investors entered at this stage

  • CBGF
  • NewMargin Ventures
  • Shanshan Venture Capital

Series B and later9 investors entered at this stage

  • Tebon Securities Co
  • CICC
  • GF Securities
  • Tianfeng Securities
  • Capital Securities
  • Highlight Capital
  • Haitong International Securities Group
  • Fortune Link Fund Management
  • BOCI
Employees 63 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇳 China93.8%
🇬🇧 United Kingdom6.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about TELLYES SCIENTIFIC on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See TELLYES SCIENTIFIC on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.